Prevalence and risk factors of diabetic peripheral neuropathy: A population-based cross-sectional study in China
- PMID: 37490047
- DOI: 10.1002/dmrr.3702
Prevalence and risk factors of diabetic peripheral neuropathy: A population-based cross-sectional study in China
Abstract
Aims: To assess the prevalence of diabetic peripheral neuropathy (DPN) and its risk factors in the type 2 diabetes mellitus (T2DM) population.
Methods: This cross-sectional study enroled patients with T2DM between July and December 2017 from 24 provinces in China. Diabetic peripheral neuropathy and its severity were assessed by the Toronto clinical scoring system, neuropathy symptoms score (NSS) and neuropathy disability score. The prevalence of DPN and its risk factors were analysed.
Results: A total of 14,908 patients with T2DM were enroled. The prevalence of DPN was 67.6%. Among 10,084 patients with DPN, 4808 (47.7%), 3325 (33.0%), and 1951 (19.3%) had mild, moderate, and severe DPN, respectively. The prevalence of DPN in females was higher than in males (69.0% vs. 66.6%, P = 0.002). The prevalence of DPN increased with age and course of diabetes and decreased with body mass index (BMI) and education level (all P for trend <0.05). The comorbidities and complications in patients with DPN were higher than in those without DPN, including hypertension, myocardial infarction, diabetic retinopathy, and diabetic nephropathy (all P < 0.001). Age, hypertension, duration of diabetes, diabetic retinopathy, diabetic nephropathy, glycated haemoglobin, high-density lipoprotein cholesterol, and lower estimated glomerular filtration rate were positively associated with DPN, while BMI, education level, fasting C-peptide, and uric acid were negatively associated with DPN.
Conclusions: Among patients with T2DM in China, the prevalence of DPN is high, especially in the elderly, low-income, and undereducated patients.
Keywords: diabetes; diabetic neuropathy; peripheral neuropathy; prevalence.
© 2023 John Wiley & Sons Ltd.
Similar articles
-
Prevalence of painful diabetic peripheral neuropathy in type 2 diabetes mellitus and diabetic peripheral neuropathy: A nationwide cross-sectional study in mainland China.Diabetes Res Clin Pract. 2023 Apr;198:110602. doi: 10.1016/j.diabres.2023.110602. Epub 2023 Mar 4. Diabetes Res Clin Pract. 2023. PMID: 36871876
-
The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.J Diabetes Complications. 2017 Nov;31(11):1624-1629. doi: 10.1016/j.jdiacomp.2017.07.010. Epub 2017 Jul 27. J Diabetes Complications. 2017. PMID: 28893495
-
The Association between Genomic DNA Methylation and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus.J Diabetes Res. 2019 Nov 3;2019:2494057. doi: 10.1155/2019/2494057. eCollection 2019. J Diabetes Res. 2019. PMID: 31781662 Free PMC article.
-
Development and validation of a risk prediction model for early diabetic peripheral neuropathy based on a systematic review and meta-analysis.Front Public Health. 2023 Feb 22;11:1128069. doi: 10.3389/fpubh.2023.1128069. eCollection 2023. Front Public Health. 2023. PMID: 36908480 Free PMC article.
-
Associations of serum low-density lipoprotein and systolic blood pressure levels with type 2 diabetic patients with and without peripheral neuropathy: systemic review, meta-analysis and meta-regression analysis of observational studies.BMC Endocr Disord. 2019 Nov 25;19(1):125. doi: 10.1186/s12902-019-0453-5. BMC Endocr Disord. 2019. PMID: 31767009 Free PMC article.
Cited by
-
The role of C-peptide in diabetes and its complications: an updated review.Front Endocrinol (Lausanne). 2023 Sep 7;14:1256093. doi: 10.3389/fendo.2023.1256093. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37745697 Free PMC article. Review.
-
Paeoniflorin: a review of its pharmacology, pharmacokinetics and toxicity in diabetes.Front Pharmacol. 2025 Apr 7;16:1551368. doi: 10.3389/fphar.2025.1551368. eCollection 2025. Front Pharmacol. 2025. PMID: 40260393 Free PMC article. Review.
-
Plantar Tissue Characteristics in People With Diabetes With and Without Peripheral Neuropathy: A Novel Explanatory Model for DPN Risk Assessment.J Diabetes. 2025 May;17(5):e70094. doi: 10.1111/1753-0407.70094. J Diabetes. 2025. PMID: 40328517 Free PMC article.
-
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in Type 2 Diabetes.Med Sci Monit. 2024 Apr 2;30:e942509. doi: 10.12659/MSM.942509. Med Sci Monit. 2024. PMID: 38561932 Free PMC article.
-
Development and internal validation of an interpretable risk prediction model for diabetic peripheral neuropathy in type 2 diabetes: a single-centre retrospective cohort study in China.BMJ Open. 2025 Apr 3;15(4):e092463. doi: 10.1136/bmjopen-2024-092463. BMJ Open. 2025. PMID: 40180384 Free PMC article.
References
REFERENCES
-
- Zhou B, Lu Y, Hajifathalian K, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513-1530. https://doi.org/10.1016/s0140-6736(16)00618-8
-
- Yang G, Kong L, Zhao W, et al. Emergence of chronic non-communicable diseases in China. Lancet. 2008;372(9650):1697-1705. https://doi.org/10.1016/s0140-6736(08)61366-5
-
- Mao W, Yip CW, Chen W. Complications of diabetes in China: health system and economic implications. BMC Publ Health. 2019;19(1):269. https://doi.org/10.1186/s12889-019-6569-8
-
- Tilly H, Gomes da Silva M, Vitolo U, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26((Suppl 5)):v116-v125. https://doi.org/10.1093/annonc/mdv304
-
- Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521-534. https://doi.org/10.1016/s1474-4422(12)70065-0
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical